OBJECTIVE: This study aimed at exploring access site-related vascular complication rates associated with the use of the vascular closure device (VCD) Angio-Seal™ in an unselected patient population undergoing elective as well as emergency coronary angiography or intervention. BACKGROUND: The VCD Angio-Seal™ is widely used to achieve hemostasis after diagnostic and interventional cardiac procedures. There are only little data on the frequency of vascular complications after the use of the VCD Angio-Seal™ in patients in non-elective settings. METHOD: In-hospital vascular complications were prospectively assessed in 4,653 consecutive cardiac catheterization procedures, which included 2,772 elective diagnostic and 960 elective percutaneous coronary interventions (PCI), and 921 emergency cardiac catheterizations in patients with NSTEMI/STEMI. In 2,077 procedures manual compression (MC) and in 2,576 procedures VCD was applied. Complication rates for manual compression and VCD use were studied and multivariate analyses performed to disclose predictors for access site-related vascular complications. RESULTS: Vascular complication rates in patients receiving MC to achieve hemostasis were similar to those receiving a VCD (MC 3.4% vs. VCD 3.2%, p = n.s.). Separate analysis of vascular complication rates for subgroups revealed a significant reduction in vascular complications for the PCI group using a VCD (MC 7.7% vs. VCD 3.2%, p = 0.003). In emergencies VCD use lead to a rise in vascular complications (MC 0.9% vs. VCD 6.3%, p < 0.001). CONCLUSIONS: In contrast to elective settings, the risk of access site-related vascular complications is significantly increased after application of the VCD Angio-Seal™ in patients undergoing emergency catheterizations for NSTEMI/STEMI compared with manual compression.
OBJECTIVE: This study aimed at exploring access site-related vascular complication rates associated with the use of the vascular closure device (VCD) Angio-Seal™ in an unselected patient population undergoing elective as well as emergency coronary angiography or intervention. BACKGROUND: The VCD Angio-Seal™ is widely used to achieve hemostasis after diagnostic and interventional cardiac procedures. There are only little data on the frequency of vascular complications after the use of the VCD Angio-Seal™ in patients in non-elective settings. METHOD: In-hospital vascular complications were prospectively assessed in 4,653 consecutive cardiac catheterization procedures, which included 2,772 elective diagnostic and 960 elective percutaneous coronary interventions (PCI), and 921 emergency cardiac catheterizations in patients with NSTEMI/STEMI. In 2,077 procedures manual compression (MC) and in 2,576 procedures VCD was applied. Complication rates for manual compression and VCD use were studied and multivariate analyses performed to disclose predictors for access site-related vascular complications. RESULTS: Vascular complication rates in patients receiving MC to achieve hemostasis were similar to those receiving a VCD (MC 3.4% vs. VCD 3.2%, p = n.s.). Separate analysis of vascular complication rates for subgroups revealed a significant reduction in vascular complications for the PCI group using a VCD (MC 7.7% vs. VCD 3.2%, p = 0.003). In emergencies VCD use lead to a rise in vascular complications (MC 0.9% vs. VCD 6.3%, p < 0.001). CONCLUSIONS: In contrast to elective settings, the risk of access site-related vascular complications is significantly increased after application of the VCD Angio-Seal™ in patients undergoing emergency catheterizations for NSTEMI/STEMI compared with manual compression.
Authors: Eugenia Nikolsky; Roxana Mehran; Amir Halkin; Eve D Aymong; Gary S Mintz; Zoran Lasic; Manuela Negoita; Martin Fahy; Shoshana Krieger; Issam Moussa; Jeffrey W Moses; Gregg W Stone; Martin B Leon; Stuart J Pocock; George Dangas Journal: J Am Coll Cardiol Date: 2004-09-15 Impact factor: 24.094
Authors: G Dangas; R Mehran; S Kokolis; D Feldman; L F Satler; A D Pichard; K M Kent; A J Lansky; G W Stone; M B Leon Journal: J Am Coll Cardiol Date: 2001-09 Impact factor: 24.094
Authors: J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook Journal: Circulation Date: 1987-07 Impact factor: 29.690
Authors: H I M Kälsch; H Eggebrecht; S Mayringer; T Konorza; B Sievers; S Sack; R Erbel; K Kroeger Journal: Clin Res Cardiol Date: 2007-09-18 Impact factor: 5.460
Authors: M Moscucci; K A A Fox; Christopher P Cannon; W Klein; José López-Sendón; G Montalescot; K White; R J Goldberg Journal: Eur Heart J Date: 2003-10 Impact factor: 29.983
Authors: Steven V Manoukian; Frederick Feit; Roxana Mehran; Michele D Voeltz; Ramin Ebrahimi; Martial Hamon; George D Dangas; A Michael Lincoff; Harvey D White; Jeffrey W Moses; Spencer B King; E Magnus Ohman; Gregg W Stone Journal: J Am Coll Cardiol Date: 2007-03-09 Impact factor: 24.094
Authors: John T Owens; Shaun Bhatty; Robert J Donovan; Andrea Tordini; Peter Danyi; Kalpesh Patel; Jacob A Wegelin; Ion S Jovin Journal: Int J Angiol Date: 2017-10-04
Authors: J Pfaff; C Herweh; M Pham; S Schönenberger; S Nagel; P A Ringleb; M Bendszus; M Möhlenbruch Journal: AJNR Am J Neuroradiol Date: 2016-06-30 Impact factor: 3.825
Authors: Ruby C Lo; Margriet T M Fokkema; Thomas Curran; Jeremy Darling; Allen D Hamdan; Mark Wyers; Michelle Martin; Marc L Schermerhorn Journal: J Vasc Surg Date: 2014-09-18 Impact factor: 4.268
Authors: Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf Journal: Clin Res Cardiol Date: 2012-05-06 Impact factor: 5.460
Authors: Martin Christ; Katharina Isabel von Auenmueller; Jeanette Liebeton; Martin Grett; Wolfgang Dierschke; Jan Peter Noelke; Irini Maria Breker; Hans-Joachim Trappe Journal: Int J Med Sci Date: 2015-03-28 Impact factor: 3.738